Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J GREENBLATT

Showing results (251-260 of 1,248) with videos related to

Pageof 125
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|November 7, 2012
Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implicationsDavid J Greenblatt, Gary K Zammit
Journal of Clinical Psychopharmacology|August 1, 1985
User unfriendly drugs--fillers, additives, excipientsR I Shader, D J Greenblatt
The Journal of Biological Chemistry|September 26, 1997
Interaction of elongation factors TFIIS and elongin A with a human RNA polymerase II holoenzyme capable of promoter-specific initiation and responsive to transcriptional activatorsG Pan, T Aso, J Greenblatt
The New England Journal of Medicine|September 2, 1976
Intramuscular injection of drugsD J Greenblatt, J Koch-Weser
Journal of Clinical Psychopharmacology|August 1, 1983
Shades of the patent medicine manR I Shader, D J Greenblatt
The American Journal of Psychiatry|June 1, 1977
Clinical implications of benzodiazepine pharmacokineticsR I Shader, D J Greenblatt
Journal of Clinical Psychopharmacology|February 1, 1987
Bioequivalence of generic drugs in clinical psychopharmacologyD J Greenblatt, R I Shader
Journal of Clinical Psychopharmacology|March 1, 1981
Antidepressants: the second harvest and DSM-IIIR I Shader, D J Greenblatt
Journal of Clinical Pharmacology|February 27, 2016
In Memoriam: David A. Flockhart, 1952-2015David J Greenblatt, Darrell R Abernethy
American Journal of Hospital Pharmacy|October 1, 1974
Rational use of psychotropic drugs. I. HypnoticsD J Greenblatt, R R Miller
Pageof 125

Showing results (251-260 of 1,248) with videos related to

Sort By:
Pageof 125
Expert Opinion on Drug Metabolism & Toxicology|November 7, 2012
Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implicationsDavid J Greenblatt, Gary K Zammit
Journal of Clinical Psychopharmacology|August 1, 1985
User unfriendly drugs--fillers, additives, excipientsR I Shader, D J Greenblatt
The Journal of Biological Chemistry|September 26, 1997
Interaction of elongation factors TFIIS and elongin A with a human RNA polymerase II holoenzyme capable of promoter-specific initiation and responsive to transcriptional activatorsG Pan, T Aso, J Greenblatt
The New England Journal of Medicine|September 2, 1976
Intramuscular injection of drugsD J Greenblatt, J Koch-Weser
Journal of Clinical Psychopharmacology|August 1, 1983
Shades of the patent medicine manR I Shader, D J Greenblatt
The American Journal of Psychiatry|June 1, 1977
Clinical implications of benzodiazepine pharmacokineticsR I Shader, D J Greenblatt
Journal of Clinical Psychopharmacology|February 1, 1987
Bioequivalence of generic drugs in clinical psychopharmacologyD J Greenblatt, R I Shader
Journal of Clinical Psychopharmacology|March 1, 1981
Antidepressants: the second harvest and DSM-IIIR I Shader, D J Greenblatt
Journal of Clinical Pharmacology|February 27, 2016
In Memoriam: David A. Flockhart, 1952-2015David J Greenblatt, Darrell R Abernethy
American Journal of Hospital Pharmacy|October 1, 1974
Rational use of psychotropic drugs. I. HypnoticsD J Greenblatt, R R Miller
Pageof 125